1994
DOI: 10.1159/000236748
|View full text |Cite
|
Sign up to set email alerts
|

Interferon-Gamma Induces lnterleukin-3 Release from Peripheral Blood Eosinophils

Abstract: Interferon-gamma (IFN-γ) upregulates eosinophil effector functions and prolongs the in vitro survival of eosinophils. We examined the possible capacity of IFN-γ to stimulate eosinophils to produce eosinophil-activating cytokines. Eosinophils purified from mild atopic volunteers were cultured with 100 U/ml IFN-γ. Viability of eosinophils was counted and supernatants were tested for the presence of cytokines by neutralization of eosinophil viability-enhancing activity with specific antibodies to IFN-γ, interleuk… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

1995
1995
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 8 publications
0
7
0
Order By: Relevance
“…The first two mechanisms are the most commonly observed in tissue biopsies from subjects with eosinophilic inflammation. A number of physiological agonists may induce the release of eosinophil granule proteins, for example, serum-opsonized surfaces [20], alternative complement factor C5a [21], immunoglobulin complexes [22] and cytokines including IL-3, IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IFN [11, [23][24][25][26]. The current thinking is that much of the airway damage associated with asthma and allergic inflammation may be related to the release of eosinophil granule proteins MBP, EPO and ECP [27][28][29][30].…”
Section: Eosinophilsmentioning
confidence: 99%
“…The first two mechanisms are the most commonly observed in tissue biopsies from subjects with eosinophilic inflammation. A number of physiological agonists may induce the release of eosinophil granule proteins, for example, serum-opsonized surfaces [20], alternative complement factor C5a [21], immunoglobulin complexes [22] and cytokines including IL-3, IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IFN [11, [23][24][25][26]. The current thinking is that much of the airway damage associated with asthma and allergic inflammation may be related to the release of eosinophil granule proteins MBP, EPO and ECP [27][28][29][30].…”
Section: Eosinophilsmentioning
confidence: 99%
“…Other more recently indicated functions of eosinophils are based on their capacity to release cytokines (1,4). Since the first report of human eosinophils as a cytokine source by our group (6), these cells are now known to synthesize numerous cytokines with multiple biologic activities including transforming growth factor‐α (TGF‐α) (6), granulocyte macrophage colony‐stimulating factor (GM‐CSF) (7), tumor necrosis factor‐α (TNF‐α) (8), interleukin (IL)‐3 (9), IL‐5 (10), IL‐4 (11), IL‐16 (12), regulated on activation, normal, T‐cell expressed and secreted (RANTES) (13), vascular endothelial growth factor (VEGF) (14), stem cell factor (SCF) (15) and IL‐13 (16). Both cytokines and distinct eosinophil cationic proteins (ECPs) are stored in preformed pools within eosinophil specific granules and can be released upon stimulation (3,5,17).…”
mentioning
confidence: 99%
“…6 The effect of IFN␥ on stimulating the release of other eosinophil-derived cytokines and chemokines has also been observed. [13][14][15] IFN␥ is a cytokine described as the prominent product of Th1-type lymphocytes in both mouse and human, 16,17 and is usually associated with a wide range of bacterial and viral infections. Serum levels of IFN␥ have been shown to be elevated in acute severe asthma.…”
mentioning
confidence: 99%